Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica
- 7 March 2014
- journal article
- case report
- Published by Wiley in Annals of Neurology
- Vol. 75 (3), 447-453
- https://doi.org/10.1002/ana.24079
Abstract
Neuromyelitis optica is a rare neurological autoimmune disorder characterized by a poor prognosis. Immunosuppression can halt disease progression, but some patients are refractory to multiple treatments, experiencing frequent relapses with accumulating disability. Here we report on durable clinical remissions after allogeneic hematopoietic stem cell transplantation in 2 patients suffering from severe forms of the disease. Immunological data evidenced disappearance of the pathogenic antibodies and regeneration of a naive immune system of donor origin. These findings correlated with evident clinical and radiological improvement in both patients, warranting extended clinical trials to investigate this promising therapeutic option. ANN NEUROL 2014;75:447–453Keywords
Funding Information
- Italian Ministry of Health
This publication has 20 references indexed in Scilit:
- Neuromyelitis opticaCurrent Opinion in Neurology, 2012
- Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 2011
- Immune tolerance in multiple sclerosisImmunological Reviews, 2011
- Current and future treatment approaches for neuromyelitis opticaTherapeutic Advances in Neurological Disorders, 2011
- EFNS guidelines on diagnosis and management of neuromyelitis opticaEuropean Journal of Neurology, 2010
- Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009Bone Marrow Transplantation, 2009
- Allogeneic hematopoietic SCT for patients with autoimmune diseasesBone Marrow Transplantation, 2009
- Autologous hematopoietic stem cell transplantation for autoimmune diseasesBone Marrow Transplantation, 2005
- Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patientsThe Journal of Experimental Medicine, 2005
- Rating neurologic impairment in multiple sclerosisNeurology, 1983